Lactiga

Lactiga™ is an award-winning, venture-backed biologics company developing patented biologics for the treatment and prevention of infectious diseases, including COVID-19, with a focus on improving the quality of life for patients with primary immunodeficiency disorders. Lactiga is unlocking the full therapeutic potential of breast milk to create the next generation of anti-infective drugs capable of combating some of the world’s most dangerous pathogens.